ArticleThe Lancet. Global health2021
Responsive and agile vaccination strategies against COVID-19 in India.
Article in The Lancet. Global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- BharatSim: An agent-based modelling framework for India.PLoS computational biology · 2024Article
- Emerging opportunities for gene editing therapies in India.Nature medicine · 2024Article
- Examining the Impact of Key Factors on COVID-19 Vaccination Coverage in India: A PLS-SEM Approach.Vaccines · 2023Article
- COVID-19 management: The vaccination drive in India.Health policy and technology · 2022Article
- COVID-19 vaccination strategies and policies in India: The need for further re-evaluation is a pressing priority.The International journal of health planning and management · 2022Article
- 'Imperfect but useful': pandemic response in the Global South can benefit from greater use of mathematical modelling.BMJ global health · 2022Article
- Article
- Optimizing COVID-19 vaccination programs during vaccine shortages.Infectious Disease Modelling · 2022Article
- Article
- Commentary: Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2.Frontiers in medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.